期刊名称：CARDIOVASCULAR RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Cardiovascular Research is concerned with both basic and clinical research in the field of cardiovascular
physiology, pathophysiology and pharmacology. The Journal welcomes submission of papers both at the molecular, subcellular, cellular, organ and organism level, and of clinically oriented papers offering insight into (patho)physiological mechanisms. Manuscripts may be submitted as Regular Papers or as Letters to the Editor. Moreover, the Journal publishes Reviews, Masterclass papers, Editorials and Invited Letters to the Editor.
Instructions to Authors
Policy
Cardiovascular Research is the International Basic Science Journal of the European Society of Cardiology. The Journal is concerned with both basic and clinical research in the field of cardiovascular physiology and pathophysiology. The Journal welcomes submission of papers both at the molecular, subcellular, cellular, organ and organism level and of clinically oriented papers offering insight into (patho)physiological mechanisms. Manuscripts may be submitted as Original Articles or as Letters to the Editor. Moreover, the Journal publishes Reviews and Editorials. An author should indicate whether his/her manuscript should be considered for one of the Spotlight Issues that address particular themes (see under "Announcements" on the Homepage for a list of upcoming topics). Manuscripts are normally evaluated by three members from an international panel of reviewers, and an editorial decision is typically made within 28 days of receipt of a manuscript.
Preparation of manuscripts (for regular papers)
The manuscript should be typed double spaced. Review articles should not exceed 7,500 words and Original articles 5,750 words, including references. Abbreviations should be kept to a minimum and should not appear in the Abstract, unless they may be understood by non-expert readership. Manuscripts should be submitted electronically. Authors presently unable to take advantage of online submission should fax the Editorial Office for further instructions (+49 641 99 47 209).
(1) Title page. This is the first page of the manuscript submission file. Title length should be no longer than 120 characters. Provide the names of all authors including first name, department where the work was performed, all author's affiliations, name of corresponding author with address, telephone number, fax and e-mail. Also give current addresses of any authors who have moved since the work was finished. The number of words should be mentioned on the title page.
(2) Abstract. The abstract should be submitted as a separate file. Repeat in normal sized, but bold font, names of the authors and the title of the manuscript at the top of the page. The abstract should not exceed one page of the manuscript. It should be structured into the subsections "Objective," "Methods," "Results" and "Conclusion(s)." Give the name of the species in the subsection "Methods."
(3) Keywords. These will be published with your article. During online submission, they are typed into a window. A maximum of 5 keywords is required for publication of the manuscript. Keywords should be selected from the alphabetically formatted list given at the end of these instructions.
(4) Classifications. These are used for administration purposes and selection of reviewers. During online submission they are chosen by ticking boxes in a formatted list. Authors should first choose classifications concerning Discipline, Object of Study, Level, and Expertise and then Keywords from the subsequent alphabetical list. Please tick as many keywords as you feel necessary to characterize your manuscript.
(5) Introduction. This section should position the study with regard to objective, rationale, and preceding work of other authors.
(6) Methods. This section should contain a statement that "The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996)," or (if human subjects are used) that "The investigation conforms with the principles outlined in the Declaration of Helsinki" (Cardiovascular Research 1997;35:2-4). The methods section should be sufficiently detailed for repetition of the study by other scientists. If pertinent, the section may be divided into headed subsections.
(7) Results. If pertinent, the section may be divided into headed subsections. For presentation of data, figures are preferred to tables. Also, extensive numerical data should appear in legends to the figures rather than in the main body of text. SI units should be used.
(8) Discussion. This section should not contain paragraphs dealing with topics that are beyond the scope of the study. Four manuscript pages should in general be enough to compare and interpret the data with regard to previous work by yourself and others.
(9) Acknowledgements.
(10) References.
Regular papers:
Coronel R, Opthof T, Taggart P, Tytgat J, Veldkamp M. Differential electrophysiology of repolarisation from clone to clinic. Cardiovasc Res 1997;33:503-517.
Books:
Wit AL, Janse MJ. The Ventricular Arrhythmias of Ischemia and Infarction. Electrophysiological Mechanisms. Mount Kisco, NY: Futura Publishing Company, Inc, 1992.
Chapter in book: Weber KT. Cardiac Interstitium: Extracellular Space of the Myocardium. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. Scientific Foundations, 2nd ed. New York: Raven Press, 1991:1465-1480.
Thesis: Dekker L.R.C. Role of intracellular calcium in ischemic damage and preconditioning in cardiac muscle. Amsterdam: University of Amsterdam. 1996 (Thesis).
Please note: If the bibliography contains more than six authors, et al. should be added following the third author.
Abstract: like regular paper, but add (Abstract) at end.
(11) Figure Legends. Figure legends should start on a new page of the manuscript, but one page may contain legends to more than one figure.
(12) Figures/Tables. These may be attached as separate files (entitled "Figure 1" or "Table 2" for example, under "Description") during the submission process or included in the manuscript file; the former method is recommended, however, as otherwise the manuscript file may be very slow to upload. Electronically submitted figures should be of high resolution and in one of the following formats: tiff, bitmap (.bmp), jpeg (.jpg), portable data format (.pdf), or postscript (.ps or .eps). Any lettering in the figures should be large enough to stand photographic reduction. Contributors should prepare their figures for either one column width (84 mm) or the entire page width (175 mm). The maximum height is 240 mm. The Publisher will determine the degree of any reduction or enlargement required and in general, line drawings will be reduced to one column width if possible.
(13) Colour Figures. If, together with your accepted article, you submit usable colour figures then Elsevier Science will ensure, at no additional charge, that these figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version. The first colour page in print will cost 681 Euro, each additional page will cost 454 Euro. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/locate/authorartwork . Please note: Because of technical complications which can arise by converting colour figures to 'grey scale' (for the printed version should you not opt for colour in print), please submit in addition usable black and white prints corresponding to all the colour illustrations.
Preparation of review articles
Review articles should be divided into the following sections: a short abstract (unstructured) followed by various subsections that may include an introduction and may also be further subdivided, and a summary or similar concluding section. The maximum number of words is 7500.
Submission
Manuscripts should be submitted electronically at the URL http://cardiovascres.edmgr.com which can also be reached from the Journal's Homepage http://www.elsevier.com/locate/cardiores . Three files are required to be uploaded for the submission process: 1) the abstract, 2) the manuscript (with title page; no PDF files, please), and 3) the covering letter including the following declarations: i) That "the manuscript, or part of it, neither has been published (except in form of abstract or thesis) nor is currently under consideration for publication by any other journal." ii) The submitting author should declare that the co-author(s) has (have) read the manuscript and approved its submission to Cardiovascular Research. iii) In the case of colour figures, the authors should declare that they agree to pay for the cost of printing. A specification of costs will be sent by publisher after final acceptance of the manuscipt. Submission of revised manuscripts: the previous version of a manuscript (and other materials such as cover letter, older version of abstract, etc.) has to be removed from the list of submission items during the submission process for revised manuscripts.
Checklist
Covering letter? - Length of Title OK? - Affiliations OK? - Title and authors repeated at top of Abstract? - Abstract structured? - Abstract length one page? - Species in Abstract? - Ethics statement? - Species in keywords list (see recent issue for list)? - Figures OK? - Color prints statement if pertinent? - Style references OK? - Double spacing?
All questions arising after acceptance of the manuscript, especially those relating to proofs, should be directed to Cardiovascular Research, Elsevier Science B.V., P.O. Box 2759, 1000 CT Amsterdam, The Netherlands; Tel.: (+31) 20 4852401; Fax: (+31) 20 4852431; E-mail: L.Vaal@elsevier.nl .
Editorial Service available in Japan: Upon request, Elsevier Science Japan will provide authors in Japan with a list of people who can check and improve the English of their paper (before submission). Please contact our Tokyo office: Elsevier Science Japan, 1-9-15, Higashi-Azabu, Minato-ku, Tokyo 106, Japan; Tel.: (+81) 3-5561-5032; Fax: (+81) 3-5561-5045.; E-mail: info@elsevier.co.jp.
Keywords
ablation
ACE inhibitors
acetylcholine
acidosis
adenosine
adrenergic (ant)agonists
aging
anesthesia
angiogenesis
angiography
angioplasty / coronary intervention
angiotensin
antiarrhythmic agents
anticoagulants
antihypertensive / diuretic agents
apoptosis
arrhythmia (mechanisms)
arteries
atherosclerosis
atrial function
autonomic nervous system
AV-node
baroreflex
blood flow
blood pressure
bradycardia
Ca-channel
Ca-pump
calcium (cellular)
calpain
capillaries
capillary permeability
cardiomyopathy
cardioplegia
cardiovascular surgery
caveolae
cell communication
cell culture / isolation
cell differentiation
cell swelling
cell therapy
cerebrovascular disorders
cholesterol
chronotropic agents
Cl-channel
collateral circulation
complement activation
computer modeling
conduction (block)
conduction system
congenital defects
connective tissue
connexins
contractile apparatus
contractile function
coronary circulation
coronary disease
cyclooxygenase
cytokines
cytoskeleton
defibrillation
developmental biology
diabetes
e-c coupling
ECG
echocardiography
edema (oedema)
electron microscopy
endothelial factors
endothelial function
endothelial receptors
endothelins
endotoxins
energy metabolism
enzyme (kinetics)
epidemiology
estrogens (oestrogens)
extracellular matrix |
fibrosis
G-proteins
gap junctions
gender
gene array analysis
gene expression
gene polymorphisms
gene therapy
gene transfer
glycolysis
glycoproteins
growth factors
heart failure
heart rate (variability)
hemodynamics
hemostasis
hibernation
histo(patho)logy
hormones
hypertension
hypertrophy
hypoxia / anoxia
hypoxia inducible factor (HIF)
immunology
impulse formation
infarction
infection / inflammation
innervation
inotropic agents
insulin
insulin resistance
interleukins
interstitial space
intra / extracellular ions
ion channels
ion exchangers
ion pumps
ion transport
ischemia
K-ATP channel
K-channel
leukocytes
lipid metabolism
lipid signaling
lipoproteins
long QT syndrome
macrophages
MAP kinase
mapping
matrix metalloproteinases
mechanotransduction
membrane currents
membrane permeability / physics
membrane potential
membrane transport
microcirculation
mitochondria
monoclonal antibodies
muscarinic (ant)agonists
myocarditis
myocytes
Na / Ca-exchanger
Na / H-exchanger
Na / K-pump
Na-channel
NADPH oxidase
natriuretic peptide
necrosis
neurotransmitters
nitric oxide
NMR
oxidative phosphorylation
oxygen consumption |
oxygen radicals
pharmacokinetics
phospholipases
phospholipids
peptide hormones
platelets
preconditioning
prostaglandins
proteases
protein kinases
protein kinase A
protein kinase C
protein kinase G
protein phosphatases
protein phosphorylation
proteomics
pulmonary circulation
Purkinje fiber
QT-dispersion
receptors
redox signaling
regional blood flow
remodeling
renal function
renin angiotensin system
reoxygenation
reperfusion
repolarization
restenosis
sarcolemma
second messengers
sepsis
septic shock
sequence (DNA / RNA / protein)
serotonin (5HT)
shock
signal transduction
single channel currents
sinus node
smooth muscle
SR (function)
statins
statistics
stem cells
stents
stretch / m-e coupling
stunning
sudden death
supraventricular arrhythmia
thrombolysis
thrombosis / embolism
transplantation
tissue engineering
transgenic animal models
tyrosine protein kinases
ultrasound
valve (disease)
vasoactive agents
vasoconstriction / dilation
veins
ventricular arrhythmias
ventricular function
viral diseases
|
Editorial Board
Editor-in-Chief:
 |
|
H.M. Piper, Cardiovascular Research, Editorial Office, Institute of Physiology, Medical Faculty, Justus Liebig University, Aulweg 129, 35392 Giessen, Germany;
Fax: (+49) 641 99 47209
Email:CVR@physiologie.med.uni-giessen.de
|
Associate Editors:
|
|
J.A. Barrabés,
|
|
D. Garcia-Dorado,
|
|
T. Noll,
|
|
M. Ruiz-Meana,
|
|
K.-D. Schlüter,
|
|
G. Taimor,
|
Consulting Editors:
|
|
G. Ambrosio, Italy
|
|
M. Avkiram, UK
|
|
M. Böhm, Germany
|
|
P.G. Camici, UK
|
|
R. Coronel, The Netherlands
|
|
F.R.E. Curry, USA
|
|
R. De Caterina, Italy
|
|
F. Di Lisa, Italy
|
|
H. Ector, Belgium
|
|
L. Field, USA
|
|
D. Fitzgerald, Ireland
|
|
I. Fleming, Germany
|
|
N. Gali? Italy
|
|
A. Goedecke, Germany
|
|
L.M. Goncalves, Portugal
|
|
A.P. Halestrap, UK
|
|
G. Heusch, Germany
|
|
M.J. Janse, The Netherlands
|
|
L.A. Kirshenbaum, Canada
|
|
R.N. Kitsis, USA
|
|
A.G. Kléber, Switzerland
|
|
T.F. Lüscher, Switzerland
|
|
S. Lamas, Spain
|
|
P. Menasch? France
|
|
J.-J. Mercadier, France
|
|
A.F. Moorman, The Netherlands
|
|
D.E. Newby, UK
|
|
T. Opthof, The Netherlands
|
|
U. Ravens, Germany
|
|
M.R. Rosen, USA
|
|
G.L. Semenza, USA
|
|
A.M. Shah, UK
|
|
M.J. Shattock, UK
|
|
K. Sipido, Belgium
|
|
C. Steenbergen, USA
|
|
P.H. Sugden, UK
|
|
G.R. Sutherland, Belgium
|
|
J. Tamargo, Spain
|
|
A. Tedgui, France
|
|
J. Vinten-Johansen, USA
|
|
H. Watanabe, Japan
|
|
K.T. Weber, USA
|
|
S. Yl?Hettuala, Finland
|
|
V.W. van Hinsbergh, The Netherlands
|
Journal Management:
|
|
E.A. Martinson, Office Manager
|
|
J. Gaspar Dörr, Office Assistant
|
|
T. Lich, Office Assistant
|
|
